Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24167 | 0.84 | CA2 (0.31) | TSHRTDP1CA2MAPK1 | |
| SCHEMBL11668371 | 0.84 | TDP1 (0.40) | TSHRTDP1CA2MAPK1MEN1 | |
| SCHEMBL11668392 | 0.81 | CA2 (0.46) | CA2MAPK1MEN1KMT2AHPGD | |
| SCHEMBL28659439 | 0.80 | CA1 (0.40) | TSHRTDP1CA2 | |
| SCHEMBL7788763 | 0.80 | CA2 (0.31) | TSHRTDP1CA2MAPK1MEN1 | |
| SCHEMBL31457230 | 0.78 | CA2 (0.54) | TSHRTDP1CA2MAPK1MEN1 | |
| SCHEMBL2363649 | 0.77 | GRIK1 (0.33) | TSHR | |
| SCHEMBL28436296 | 0.77 | CA2 (0.37) | CA2MAPK1MEN1KMT2AHPGD | |
| SCHEMBL5611403 | 0.76 | CA2 (0.40) | TSHRCA2MAPK1MEN1KMT2A | |
| SCHEMBL276534 | 0.72 | CA2 (0.41) | TSHRTDP1CA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1066 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624315-B2 | Consumer products comprising delivery particles with high core:wall ratios | THE PROCTER & GAMBLE COMPANY (US) | 2026-05-12 | — | — | US | claimed |
| EP-4437040-B1 | MOULDED ARTICLE BASED ON FLAME RETARDANT ELASTOMER COMPOSITION FOR THE FIRE PROTECTION , PROCESS FOR ITS PRODUCTION AND CORRESPONDING MOULDED ARTICLES | HILTI AG (LI) | 2025-07-30 | — | — | EP | claimed |
| EP-4479475-A2 | MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM | Newlight Technologies, Inc. (US) | 2024-12-25 | — | — | EP | claimed |
| EP-4437039-A1 | FLAMEPROOF ELASTOMER COMPOSITION, METHOD FOR PRODUCING SAME, AND USE THEREOF FOR FIREPROOFING APPLICATIONS | ContiTech Deutschland GmbH (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240206461-A1 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | ENCAPSYS, LLC (US) | 2024-06-27 | — | — | US | claimed |
| EP-4370644-A1 | CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | The Procter & Gamble Company (US) | 2024-05-22 | — | — | EP | claimed |
| EP-4369931-A2 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Encapsys, LLC (US) | 2024-05-22 | — | — | EP | claimed |
| EP-4355472-A1 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | Encapsys, LLC (US) | 2024-04-24 | — | — | EP | claimed |
| EP-4355848-A1 | CONSUMER PRODUCTS COMPRISING DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | The Procter & Gamble Company (US) | 2024-04-24 | — | — | EP | claimed |
| US-20240122176-A1 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | ENCAPSYS, LLC (US) | 2024-04-18 | — | — | US | claimed |
| EP-0504920-A2 | Scorch retarding curing/crosslinking compositions | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-09-23 | — | — | EP | claimed |
| EP-0259537-B1 | PROCESS FOR REDUCING RESIDUAL MONOMERS IN LOW VISCOSITY POLYMER-POLYOLS | ATOCHEM NORTH AMERICA, INC. (a Pennsylvania corp.) (US) | 1992-03-25 | — | — | EP | claimed |
| US-5070124-A | HEAT AND OXIDATION RESISTANCE | ATOCHEM NORTH AMERICA, INC. (US) | 1991-12-03 | — | — | US | claimed |
| EP-0429878-A1 | Sulfide antioxidants for stabilizing crosslinked polyolefins | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1991-06-05 | — | — | EP | claimed |
| US-4873274-A | In-mold coating powders with two initiators or 1,1-di(t-butylperoxy)-3,3,5-trimethylcyclohexane as a single initiator | MORTON THIOKOL, INC. (US) | 1989-10-10 | — | — | US | claimed |
| US-4861827-A | Continuous process for the production of high impact polystyrene using non-acid forming initiators | FINA TECHNOLOGY, INC. (US) | 1989-08-29 | — | — | US | claimed |
| EP-0323428-A2 | Continuous process including recycle stream treatment for the production of high impact polystyrene | FINA TECHNOLOGY, INC. (US) | 1989-07-05 | — | — | EP | claimed |
| EP-0309088-A2 | In-mold coating powder containing 1,1'-di(t-butylperoxy)-3,3,5-trimethylcyclohexane as an initiator. | MORTON INTERNATIONAL, INC. (US) | 1989-03-29 | — | — | EP | claimed |
| US-4328360-A | VULCANIZING AGENT FOR THERMOPLASTIC RESINS | PENNWALT CORPORATION (US) | 1982-05-04 | — | — | US | claimed |
| US-4129703-A | Free-radical polymerizations using mixed initiator systems at two thermally distinct polymerization stages | PENNWALT CORPORATION (US) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240206461-A1 | DELIVERY PARTICLES WITH HIGH CORE:WALL RATIOS | CETP, CHMP4B, HDLBP | TSHR 4722/4885TDP1 2741/4885CA2 4264/4885 |
| US-12624315-B2 | Consumer products comprising delivery particles with high core:wall ratios | PAM, ACR, MATR3 | TSHR 4078/4885TDP1 1304/4885CA2 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.